Detrimental effect of delayed or incomplete BCG protocols administration after trans-urethral tumor resection in patients with non-muscle-invasive bladder cancer: a systematic review

Key Points

• This review aims to assess the consequences of delayed or incomplete BCG administration following trans-urethral tumor resection in bladder cancer patients.
• Systematic review of existing literature on BCG treatment schedules and their impact on recurrence rates.
• Analysis of endoscopic follow-up protocols and their importance in cases of treatment delay.
• Adhering to standard BCG schedules significantly lowers the likelihood of cancer recurrence.
• In cases of treatment delays, meticulous endoscopic follow-up is essential to manage potential relapses.

Abstract